患有酒精使用障碍的患者的渴望和阿坎普罗沙特治疗反应的生物标志物:来自多omics的见解
Ming-Fen Ho1,2, Cheng Zhang3, Brandon J Coombes4
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. ho.mingfen@mayo.edu.
Molecular psychiatry
|February 25, 2026
概括
研究人员确定HSD11B1和皮质醇是酒精渴望强度和酒精使用障碍 (AUD) 治疗反应的潜在生物标志物. 这项研究使用了多项OMIC数据,以找到对渴望和治疗成功的客观标记.
科学领域:
- 生物化学 生物化学
- 基因组学就是基因组学.
- 神经科学是一个神经科学.
背景情况:
- 目前缺乏对酒精渴望强度和酒精使用障碍 (AUD) 治疗反应的客观生化标志物.
- 梅奥诊所的阿坎普罗沙特研究提供了一个独特的机会,可以使用多omics数据来调查潜在的生物标志物.
研究的目的:
- 为了确定与酒精渴望强度相关的潜在生物标志物.
- 探索生物标志物和对AUD的阿坎普罗沙特治疗反应之间的关系.
主要方法:
- 在一个开放标签的阿卡姆普罗沙特试验中,从442名参与者的基线血样本中进行了多个omics分析 (OLINK"探索炎症"面板).
- 分析临床数据,包括酒精消费和渴望强度.
- 使用患者衍生诱导多能干细胞 (iPSC) 的功能基因组研究.
主要成果:
- 基线渴望强度是复发的最强的临床预测因素 (p:9.36E-06).
- 血中的HSD11B1 (皮质素转皮质醇酶) 和皮质醇水平与渴望强度和阿坎普酸治疗结果有关.
- 一项全基因组关联研究 (GWAS) 在KHNYN和CBLN3基因中发现了与血皮质醇水平和阿坎普罗沙特治疗反应相关的显著SNP.
结论:
- 在AUD中,HSD11B1和皮质醇显示出作为酒精渴望强度的客观生物标志物具有前途.
- KHNYN和CBLN3基因集群可能在调节皮质醇代谢和干扰素信号传递方面发挥作用,从而影响治疗反应.
- 这项研究为酒精渴望的生物化学基础和阿坎普罗沙特治疗疗效提供了新的见解.
更多相关视频
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.9K
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.7K
相关概念视频
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
